Utilizzo del pentaglobin nel trattamento della sepsi nel paziente sottoposto a chemioipertermia intraperitoneale (CIIP).

Translated title of the contribution: Use of pentaglobin in the treatment of sepsis in the patient undergoing intraperitoneal hyperthermic chemotherapy

M. Vaira, S. Scuderi, D. Costamagna, R. Barone, M. De Simone

Research output: Contribution to journalArticle

Abstract

In patients subjected to cytoreduction and hyperthermic antiblastic peritoneal perfusion (HAPP), their immunocompromized conditions claim a very aggressive therapeutic approach in case of periotonitis and sepsis. Therefore, we use an adjuvant therapy of severe bacterial infections additional to antibiotic therapy by using Pentaglobin. It contains human plasma proteins, of which immunoglobulin at least 95%, with high rate of IgG, IgM and IgA, infused intravenously at 12 mL/h for 3 days continuously. From November 2000 to March 2003, we combined this approach for the treatment of peritonitis/sepsis in 11 patients. In 10 patients we obtained a complete control of the infective status in 8 days, while 1 patient died for MOFF. So, even with the exiguity of our casuistry, we obtained a better and more rapid clinical control of the patients respect to the previous period when the Pentaglobin was not used.

Translated title of the contributionUse of pentaglobin in the treatment of sepsis in the patient undergoing intraperitoneal hyperthermic chemotherapy
Original languageItalian
Pages (from-to)296-297
Number of pages2
JournalTumori
Volume89
Issue number4 Suppl
Publication statusPublished - Jul 2003

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Use of pentaglobin in the treatment of sepsis in the patient undergoing intraperitoneal hyperthermic chemotherapy'. Together they form a unique fingerprint.

  • Cite this